How did ABVC's revenue and expenses shift in Q3 2024 compared to previous quarters?

ABVC BioPharma experienced a significant increase in revenue in Q3 2024, with the total revenue reported at $389,276, compared to $117,142 in Q2 2024. However, the company's expenses for Q3 2024 are not currently available, making it difficult to assess the net financial performance for the period. |code|Ticker|Name|Date|Total Revenue|Total Expenses|market_code| |---|---|---|---|---|---|---| |ABVC|ABVC.O|ABVC BioPharma|2023 Q4|2165||186| |ABVC|ABVC.O|ABVC BioPharma|2024 Q1|1205||186| |ABVC|ABVC.O|ABVC BioPharma|2024 Q2|117142||186| |ABVC|ABVC.O|ABVC BioPharma|2024 Q3|389276||186| |code|Ticker|Name|Date|Total Revenue|Total Expenses|market_code| |---|---|---|---|---|---|---| |ABVC|ABVC.O|ABVC BioPharma|2023 Q3|15884||186| |ABVC|ABVC.O|ABVC BioPharma|2023 Q4|2165||186| |ABVC|ABVC.O|ABVC BioPharma|2024 Q1|1205||186| |ABVC|ABVC.O|ABVC BioPharma|2024 Q2|117142||186|